- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by HEM Pharma Inc.
Total 2395 results
-
Astellas Pharma Korea, Inc.Completedde Novo Kidney TransplantationKorea, Republic of
-
Astellas Pharma IncAstellas Pharma Canada, Inc.CompletedKidney TransplantationCanada, United States
-
Astellas Pharma IncAstellas Pharma Taiwan, Inc.CompletedSleep Initiation and Maintenance Disorders | Primary InsomniaTaiwan
-
Astellas Pharma IncAstellas Pharma Korea, Inc.CompletedIgA NephropathyKorea, Republic of
-
Astellas Pharma China, Inc.CompletedHealthy | Pharmacokinetics of Tamsulosin HydrochlorideChina
-
Astellas Pharma IncAstellas Pharma Korea, Inc.CompletedOver Active BladderKorea, Republic of
-
Astellas Pharma IncAstellas Pharma Canada, Inc.Completed
-
Astellas Pharma IncAstellas Pharma Taiwan, Inc.CompletedHealthy Volunteer | Pharmacokinetics of YM178Taiwan
-
Astellas Pharma Korea, Inc.CompletedKidney TransplantationKorea, Republic of
-
Astellas Pharma IncAstellas Pharma Canada, Inc.Completed
-
Astellas Pharma IncAstellas Pharma US, Inc.TerminatedProstatic Neoplasms | Hormone-Refractory Prostate CancerUnited States, Ireland, Australia, France, United Kingdom, Belgium, Germany, Netherlands, Poland, Spain
-
Astellas Pharma IncAstellas Pharma China, Inc.CompletedOveractive BladderChina
-
Astellas Pharma IncAstellas Pharma Taiwan, Inc.CompletedLiver Transplantation | Transplantation Immunology | Host vs Graft ReactionTaiwan
-
Astellas Pharma IncAstellas Pharma US, Inc.CompletedPsoriasisUnited States, Canada
-
Astellas Pharma IncAstellas Pharma US, Inc.CompletedCerebrovascular AccidentCanada, Belgium, United States, Germany, South Africa, Austria
-
Astellas Pharma IncAstellas Pharma US, Inc.CompletedAcute Ischemic StrokeCanada, United States, Germany, Belgium, Austria
-
Vifor Pharma, Inc.TerminatedHyperkalemiaUnited States, Bulgaria, Canada, Georgia, Germany, Poland, Ukraine
-
Astellas Pharma IncAdvanz PharmaCompletedAtrial Fibrillation | Atrial FlutterUnited States, Argentina, Canada, Chile, Denmark, Mexico, Sweden
-
Astellas Pharma China, Inc.Seagen Inc.Active, not recruitingMetastatic Urothelial CancerChina
-
Vifor Pharma, Inc.RecruitingHyperkalemiaUnited States, Israel
-
Astellas Pharma IncAdvanz PharmaCompletedAtrial FibrillationUnited States, South Africa, Canada, Argentina, Denmark, Sweden
-
Astellas Pharma Korea, Inc.Seagen Inc.RecruitingUrothelial CancerKorea, Republic of
-
Astellas Pharma Global Development, Inc.Not yet recruitingClaudin 18.2 (CLDN18.2) Positive Metastatic Pancreatic Adenocarcinoma
-
Astellas Pharma Global Development, Inc.RecruitingNeurogenic Detrusor OveractivityPhilippines, Turkey, Belgium, Denmark
-
Astellas Pharma Global Development, Inc.RecruitingAcute Myeloid Leukemia (AML) | FLT3-mutated Acute Myeloid LeukemiaUnited States
-
Astellas Pharma Global Development, Inc.RecruitingAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)United States, Canada, Germany, Italy, Spain, United Kingdom, France
-
Astellas Pharma Global Development, Inc.Active, not recruitingAdvanced Cancer | Advanced MalignanciesUnited States
-
Astellas Pharma Global Development, Inc.Active, not recruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Spain, Taiwan, United Kingdom
-
Astellas Pharma Global Development, Inc.Active, not recruitingStargardt's Macular DystrophyItaly, United States, Israel, United Kingdom, Germany, Spain, Hungary, France
-
Astellas Pharma Global Development, Inc.Active, not recruitingAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) MutationUnited States, Japan, Taiwan, Spain, Australia, Belgium, Canada, France, Germany, Italy, Korea, Republic of, Poland, United Kingdom
-
Astellas Pharma Global Development, Inc.Active, not recruitingAge-Related Macular Degeneration | Geographic AtrophyUnited States, Italy, Latvia, France, Israel, Germany, Spain, Hungary, Brazil, Canada, Argentina, Colombia, Croatia, Australia, Austria, Belgium, Czechia
-
Astellas Pharma Global Development, Inc.CompletedInvasive Aspergillosis | Invasive MucormycosisUnited States, Belgium, Spain
-
Astellas Pharma Global Development, Inc.TerminatedReduced Maximum Oxygen Uptake Due to Poor Systemic Oxygen ExtractionUnited States
-
Astellas Pharma Global Development, Inc.CompletedMyelodysplastic Syndrome | Acute Myeloid Leukemia (AML)United States, Japan
-
Astellas Pharma Global Development, Inc.CompletedHot FlashesUnited States, Canada, Czechia, Hungary, Poland, Spain, United Kingdom
-
Astellas Pharma Global Development, Inc.CompletedRenal Impairment | Healthy VolunteersUnited States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedHealthy SubjectsUnited States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedTumors | Incurable Platinum Refractory Germ Cell TumorsUnited States
-
Astellas Pharma Global Development, Inc.TerminatedAcute Myeloid LeukemiaCanada, United States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder (OAB)United States, Canada
-
Astellas Pharma Global Development, Inc.CompletedHealthy | Hepatic ImpairmentUnited States
-
Astellas Pharma Global Development, Inc.CompletedInvasive Fungal InfectionUnited States
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder | Benign Prostatic HyperplasiaUnited States, Canada, Czechia, France, Germany, Italy, Poland, Spain, United Kingdom
-
Astellas Pharma Global Development, Inc.CompletedCLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction | CLDN18.2-positive Adenocarcinoma of Esophagus | CLDN18.2-positive Gastric AdenocarcinomaBulgaria, Czechia, Germany, Latvia, Russian Federation, Ukraine